News

FINANCIAL TIMES | Delivery dilemma for medical marijuana

Published: 20 November 2018

For historical reasons, marijuana escaped the typical phases of a clinical study,” says Dr Gabriella Gobbi of the Faculty of Medicine at . “This is why we have medical cannabis but we don’t know its side effects.” Whether there is interaction with anti-depressants, she adds, “we don’t know.”

Back to top